Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Zarling

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Transplantation Proceedings|December 1, 1981
Characterization of alloantigen-activated human lymphocytes cytotoxic for autologous EB virus-transformed lymphoblastoid cell linesJ M Zarling
AIDS (London, England)|January 1, 1988
Primate models for evaluation of AIDS vaccinesJ M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1984
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigensM Yasukawa, J M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1983
Autologous herpes simplex virus-infected cells are lysed by human natural killer cellsM Yasukawa, J M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivitiesM Yasukawa, J M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex virusesM Yasukawa, J M Zarling
The Journal of Experimental Medicine|May 1, 1978
Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell linesJ M Zarling, F H Bach
Journal of the National Cancer Institute|January 1, 1973
Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejectionJ M Zarling, S S Tevethia
Blood|February 1, 1984
Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cellsN E Kay, J M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte culturesS M Hurrell, J M Zarling
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Transplantation Proceedings|December 1, 1981
Characterization of alloantigen-activated human lymphocytes cytotoxic for autologous EB virus-transformed lymphoblastoid cell linesJ M Zarling
AIDS (London, England)|January 1, 1988
Primate models for evaluation of AIDS vaccinesJ M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1984
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigensM Yasukawa, J M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1983
Autologous herpes simplex virus-infected cells are lysed by human natural killer cellsM Yasukawa, J M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivitiesM Yasukawa, J M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex virusesM Yasukawa, J M Zarling
The Journal of Experimental Medicine|May 1, 1978
Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell linesJ M Zarling, F H Bach
Journal of the National Cancer Institute|January 1, 1973
Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejectionJ M Zarling, S S Tevethia
Blood|February 1, 1984
Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cellsN E Kay, J M Zarling
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte culturesS M Hurrell, J M Zarling
Pageof 7